A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies

Published:2009-11 Issue:11 Volume:8 Page:2983-2991
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Bekaii-Saab Tanios S.,Roda Julie M.,Guenterberg Kristan D.,Ramaswamy Bhuvanaswari,Young Donn C.,Ferketich Amy K.,Lamb Tammy A.,Grever Michael R.,Shapiro Charles L.,Carson William E.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-term, nonsurgical periodontal therapy boosts interleukin-12 levels and reduces oral cancer risk;Irish Journal of Medical Science (1971 -);2024-05-03

2. Current advances in targeted therapy for metastatic colorectal cancer – Clinical translation and future directions;Cancer Treatment Reviews;2024-04

3. Uncovering the Interleukin-12 Pharmacokinetic Desensitization Mechanism and Its Consequences with Mathematical Modeling;2024-02-23

4. Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials;Cancer Research Communications;2024-01-10

5. A review of targeted therapy and immune checkpoint inhibitors for metastatic colorectal cancer;Surgical Oncology;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP